ClearStar Sponsors Free Webinar with Current Consulting Group (CCG) on How to Overcome Turnaround Issues with Drug Test Results

On Wednesday, July 20, 2022, ClearStar – a leading Human Resources (HR) technology firm offering background, drug, and health screening – will sponsor a free webinar on “How to Overcome Turnaround Issues in Receiving Drug Test Results” that will be presented by Bill Current, the President and Founding Partner of the Current Consulting Group, LLC (CCG). Current founded CCG – the #1 recognized brand name in compliance, business development, and operations consulting in the drug testing industry – in 1998. He also created Current Compliance, the only comprehensive online subscription database on all state laws related to workplace drug testing, and has written several books on substance-related issues. During the free webinar that will take place from 2:00 PM to 3:00 PM Eastern Time (11:00 AM to 12:00 PM Pacific Time), Current will present five key things that every employer should know about how to get accurate and reliable drug test results faster so important employment decisions can be made as soon as possible. Learning objectives of the webinar will include:

• The main causes for delays in receiving drug test results.
• How alternative testing methods can help.
• How the use of electronic Custody Control Forms (CCFs) can speed up the process.
• The advantages of an in-house Medical Review Officer (MRO).
• The importance of using a single site if you also require occ health services.

The COVID-19 pandemic has had a direct impact on workplace drug testing programs, from getting samples collected to receiving results in a timely manner. In fact, turnaround time on drug test results has proven to be a lingering issue for many employers. However, there are things a company can do to speed up the process. Please join Bill Current of CCG for a timely free webinar on “How to Overcome Turnaround Issues in Receiving Drug Test Results” sponsored by ClearStar where he will discuss the root causes for delays in receiving drug-test results and describe specific suggestions for what employers can do to improve turnaround times. To register for the free webinar, click here. ClearStar – a portfolio company of Hanover Investors – offers a variety of customizable drug and clinical testing solutions that are fully integrated with major laboratories. ClearStar’s ClearMD streamlines the drug and clinical test ordering process to help eliminate the errors and hassles of paper forms. To learn more, contact ClearStar today. © 2022 ClearStar. All rights reserved. – Making copies of or using any part of the ClearStar website for any purpose is prohibited unless written authorization is first obtained from ClearStar. ClearStar does not provide or offer legal services or legal advice of any kind or nature. Any information on this website is for educational purposes only.

At ClearStar, we are committed to your success. An important part of your employment screening program involves compliance with various laws and regulations, which is why we are providing information regarding screening requirements in certain countries, region, etc. While we are happy to provide you with this information, it is your responsibility to comply with applicable laws and to understand how such information pertains to your employment screening program. The foregoing information is not offered as legal advice but is instead offered for informational purposes. ClearStar is not a law firm and does not offer legal advice and this communication does not form an attorney client relationship. The foregoing information is therefore not intended as a substitute for the legal advice of a lawyer knowledgeable of the user’s individual circumstances or to provide legal advice. ClearStar makes no assurances regarding the accuracy, completeness, or utility of the information contained in this publication. Legislative, regulatory and case law developments regularly impact on general research and this area is evolving rapidly. ClearStar expressly disclaim any warranties or responsibility or damages associated with or arising out of the information provided herein.